Clashing Over Rx/Dx Rights, Roche Files Suit Against DxS to Enforce Distribution Deal for KRAS, EGFR Tests

DxS denies allegations in a lawsuit filed by Roche last week that the UK-based diagnostics company is trying to renege on a distribution agreement between the two firms for KRAS and EGFR mutations tests.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.